Industry News
Stem cells offer insights into Huntington's disease
A human stem cell model that recapitulates the pathology of Huntington's disease offers insights into the cause and progression of the disease. [ + ]
The constants are still constant
Researchers have improved the constraints on time-variation of fundamental constants by making measurements of two optical clock transitions in the same atom (ytterbium). Their experiments have shown that one essential fundamental constant - the mass ratio of protons to electrons - can have changed only by a maximum of one part in a million over the age of our solar system. [ + ]
Coin-sized device could detect gravitational waves
Physicists from The University of Western Australia have invented a tiny detector, about the size of a coin, which they claim could observe gravitational waves - ripples in space-time generated by accelerating massive objects. [ + ]
VCGS signs deal to offer prenatal test
Murdoch Childrens' VCGS division has entered an agreement with Illumina allowing it to offer non-invasive prenatal testing for Down syndrome and other genetic disorders.
[ + ]TGA approval for antioxidant
Riding on the strength of a clinical trial that showed glutathione boosts immune function, Trans Chem has launched Setria Glutathione to the Australian market.
[ + ]Industry launches AIM Incentive policy paper in Canberra
AusBiotech and Australian industry leaders presented the Australian Innovation & Manufacturing (AIM) Incentive to members and senators at Parliament in Canberra this morning, declaring the model a 'good' patent box solution that would boost Australia's manufacturing industry and international competitiveness.
[ + ]Phylogica secures EU patent for Phylomer libraries
Phylogica (ASX:PYC) has received a notice of allowance for an EU patent covering its synthetic Phylomer libraries, which have applications in biosensors and personalised medicine.
[ + ]STA wins TGA approval for Iclusig in leukaemia
Specialised Therapeutics Australia has secured TGA approval for ARIAD Pharmaceuticals' Iclusig in two types of leukaemia.
[ + ]CTC test inventor coming to Australia
Professor Katharina Pachmann, the inventor of a simple blood test which utilises circulating epithelial tumour cells (CTCs) to monitor the activity of cancer, will be presenting at a number of events in Australia and New Zealand in early December. [ + ]
Scientex turns 20
Scientific instrument supplier Scientex has passed a milestone, with November 2014 marking the company's 20th anniversary of providing highly technical instruments to a range of scientific research sectors. [ + ]
Academy announces 2015 scientific excellence awards
The Australian Academy of Science has announced the winners of honorific awards for scientific excellence. The awards were established to recognise distinguished research in two categories: medals and prizes for early- and mid-career scientists up to 15 years post-PhD; and career awards for scientists of lifelong achievement. [ + ]
Calzada to divest its Metabolic subsidiary
Calzada (ASX:CZD) plans to pursue a sale or spin-off of its Metabolic Pharmaceuticals subsidiary to hand over responsibilities for funding the development of peptide fragment AOD9604.
[ + ]Paradigm BioPharmaceuticals launches $13.5m IPO
Melbourne's Paradigm BioPharmaceuticals will raise up to $13.5m via an ASX IPO to help raise funds for trials of legacy drug PPS as a treatment for bone marrow edema (BME).
[ + ]